Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut

Molecular Genetics and Metabolism

Volumn 101, Issue 2-3, 2010, Pages 200-204

  Collins, Sorcha A ^a   Sinclair, Graham ^a   McIntosh, Sarah ^a   Bamforth, Fiona ^b   Thompson, Robert ^c   Sobol, Isaac ^d   Osborne, Geraldine ^d   Corriveau, Andre ^e   Santos, Maria ^e   Hanley, Brendan ^f   Greenberg, Cheryl R ^c   Vallance, Hilary ^a   Arbour, Laura ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d Government of Nunavut   (Canada)

^e DEPARTMENT OF ENVIRONMENT AND NATURAL RESOURCES   (Canada)

^f Government of Yukon   (Canada)

Author keywords

Carnitine palmitoyltransferase 1A; Fatty acid oxidation; First Nations; Hypoglycemia; Inuit; Newborn screening

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; ISOENZYME;

ABORIGINE; ARTICLE; CANADA; ESKIMO; ETHNICITY; FATTY ACID OXIDATION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATIC ENCEPHALOPATHY; HOMOZYGOSITY; HUMAN; HYPOGLYCEMIA; NEWBORN SCREENING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEIZURE; SUDDEN INFANT DEATH SYNDROME; UNITED STATES;

CARNITINE O-PALMITOYLTRANSFERASE; GENE FREQUENCY; HUMANS; INFANT, NEWBORN; INUITS; NEONATAL SCREENING; NORTHWEST TERRITORIES; NUNAVUT; PREVALENCE; YUKON TERRITORY;

METIS;

EID: 77957222253     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2010.07.013     Document Type: Article

References (23)

1. Bonnefont J., Demaugre F., Prip-Buus C., Saudubray J.M., Brivet M., Abadi N., Thuillier L. Carnitine palmitoyltransferase deficiencies. Mol. Genet. Metab. 1999, 68:424-440.
2. Bougnères P.F., Saudubray J.M., Marsac C., Bernard O., Odièvre M., Girard J. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J. Pediatr. 1981, 98:742-746.
3. McGarry J.D., Mannaerts G.P., Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J. Clin. Invest. 1977, 60:265-270.
4. Prasad C., Johnson J.P., Bonnefont J., Dilling L.A., Innes A.M., Haworth J.C., Beischel L., Thuillier L., Prip-Buus C., Singal R., Thompson J.R., Prasad A.N., Buist N., Greenberg C.R. Hepatic carnitine palmitoyl transferase 1 (CPT1 A) deficiency in North American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program. Mol. Genet. Metab. 2001, 73:55-63.
5. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 1997, 244:1-14.
6. Price N., van der Leij F., Jackson V., Corstorphine C., Thomson R., Sorensen A., Zammit V. A novel brain-expressed protein related to carnitine palmitoyltransferase I. Genomics 2002, 80:433-442.
7. Brown N.F., Mullur R.S., Subramanian I., Esser V., Bennett M.J., Saudubray J., Feigenbaum A.S., Kobari J.A., Macleod P.M., McGarry J.D., Cohen J.C. Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme. J. Lipid Res. 2001, 42:1134-1142.
8. Seargeant L.E., Stier A., Prasad C., Grewar D.A., Chan A., Bamforth F., Macleod P.M., IJlst L., Wanders R.J.A., Greenberg C.R. Preliminary evidence for high frequency of combined CPT1 and CPT2 mutations in the Canadian Inuit [abstract]. J. Inherit. Metab. Dis. 2003, 26:97.
9. Greenberg C.R., Dilling L.A., Thompson G.R., Seargeant L.E., Haworth J.C., Phillips S., Chan A., Vallance H.D., Waters P.J., Sinclair G., Lillquist Y., Wanders R.J.A., Olpin S.E. The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations. Mol. Genet. Metab. 2009, 96:201-207.
10. Koeller D.M. Carnitine palmitoyltransferase 1A deficiency & newborn screening: implications for public health [abstract]. Mol. Genet. Metab. 2008, 93:229.
11. Raff M.L., Trahms C., Hahn S.H., Parisi M.A., Hannibal M., Glass I.A., LeBlond C., Bennett M.J., Schubert P. Clinical manifestations and consequences of the P479L mutation of carnitine palmitoyl transferase type 1 deficiency in the Alaskan native population [abstract] 2007.
12. Sinclair G., Ma J., Macleod P.M., Arbour L., Vallance H.D. Retrospective genotyping of newborn screening cards for the P479L carnitine palmitoyltransferase (CPT1) variant: correlation with acylcarnitine profiles and estimation of incidence in British Columbia [abstract]. Mol. Genet. Metab. 2007, 90:262.
13. Fingerhut R., Röschinger W., Muntau A.C., Dame T., Kreischer J., Arnecke R., Superti-Furga A., Troxler H., Liebl B., Olgemöller B., Roscher A.A. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin. Chem. 2001, 47:1763-1768.
14. Innes A.M., Seargeant L.E., Balachandra K., Roe C.R., Wanders R.J., Ruiter J.P., Casiro O., Grewar D.A., Greenberg C.R. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr. Res. 2000, 47:43-45.
15. Rajakumar C., Ban M.R., Cao H., Young T.K., Bjerregaard P., Hegele R.A. Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I. J. Lipid Res. 2009, 50:1223-1228.
16. Statistics Canada, Aboriginal Peoples in Canada in 2006: Inuit, Métis and First Nations, 2006 Census: Findings 2008.
17. Statistics Canada, Table 102-0507-Infant mortality, by age group, Canada, provinces and territories, annual, CANSIM (database) 2010.
18. Luo Z., Senecal S., Simonet F., Guimond E., Penney C., Wilkins R. Birth outcomes in the Inuit-inhabited areas of Canada. CMAJ 2010, 182:235-242.
19. Chace D.H., DiPerna J.C., Mitchell B.L., Sgroi B., Hofman L.F., Naylor E.W. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin. Chem. 2001, 47:1166-1182.
20. Boles R.G., Buck E.A., Blitzer M.G., Platt M.S., Cowan T.M., Martin S.K., Yoon H., Madsen J.A., Reyes-Mugica M., Rinaldo P. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J. Pediatr. 1998, 132:924-933.
21. Dewailly E., Blanchet C., Lemieux S., Sauvé L., Gingras S., Ayotte P., Holub B.J. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 2001, 74:464-473.
22. Sharma S., Cao X., Roache C., Buchan A., Reid R., Gittelsohn J. Assessing dietary intake in a population undergoing a rapid transition in diet and lifestyle: the Arctic Inuit in Nunavut, Canada. Br. J. Nutr. 2010, 103:749-759.
23. Guèvremont A., Kohen D. Inuit Children's Health: A Report Using the 2001 Aboriginal Peoples Survey (Children and Youth Component), Statistics Canada 2007.